Zenith Drugs Limited IPO
Zenith Drugs Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹75–₹79 per share. The stock debuted at ₹110, delivering a listing gain of 39.2%. The IPO had a lot size of ₹1600 shares and a minimum investment of ₹1,26,400.
Zenith Drugs Limited IPO
- IPO Dates
- Feb 19, 2024 – Feb 22, 2024
- Price band
- ₹75-79 per equity share
- Minimum Investment
- ₹1,26,400
- Issue size
- ₹40.68 Cr
- Lot size
- 1600
- Allotment Date
- Feb 23, 2024
- Listing
- Feb 27, 2024
- Listing At
- NSE SME
IPO timeline
-
Feb 19, 2024
Open Date
Completed
-
Feb 22, 2024
Close Date
Completed
-
Feb 23, 2024
Allotment Date
Completed
-
Feb 27, 2024
Listing Date
Completed
Zenith Drugs Limited IPO Essentials
Zenith Drugs Limited IPO Details
Zenith Drugs Limited IPO is priced at ₹75-79 per share with a total issue size of 40.68 crore. The IPO has a lot size of 1600 shares and is listed on NSE SME.
- Issue price
- ₹75-79 per equity share
- Lot size
- 1600 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 5,148,800 shares(aggregating up to ₹40.68 Cr)
- Total issue size
- 51,48,800 shares
(aggregating up to ₹40.68 crore) - Fresh issue
- 51,48,800 shares
(aggregating up to ₹40.68 crore) - Listing at
- NSE SME
- List price
- 110.0
- Listing date
- Registrar
- Bigshare Services Pvt Ltd
- Lead manager
-
Gretex Corporate Services Limited
Market Lot Size
Investors can bid for a minimum of 1600 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 1600 | ₹1,26,400 |
| Retail(max) | 1 | 1600 | ₹1,26,400 |
| NII (min) | 2 | 3,200 | ₹2,52,800 |
Zenith Drugs Limited IPO Reservation
Zenith Drugs Limited IPO reservation details show category-wise allocation of shares. Out of the total 5,148,800 shares, approximately 16.69% are reserved for QIB, 12.52% for NII, 29.21% for retail investors, 16.56% for market maker, and 25.02% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 1,288,000 (25.02%) | |
| Market Maker Shares Offered | 852,800 (16.56%) | |
| QIB Shares Offered | 859,200 (16.69%) | |
| NII (HNI) Shares Offered | 644,800 (12.52%) | |
| Retail Shares Offered | 1,504,000 (29.21%) | |
| Total Shares Offered | 5,148,800 (100%) |
Zenith Drugs Limited IPO Analytics
Zenith Drugs Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Zenith Drugs Limited IPO Subscription Status
Zenith Drugs Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 859,200 / 644,800 | 1,504,000 | 3,008,000 |
|
Day 1
19-02-24 06:00 PM
|
(0.00 / 0.99) x | 3.42 x | 1.92 x |
|
Day 2
20-02-24 06:00 PM
|
(3.53 / 2.50) x | 9.41 x | 6.25 x |
|
Day 3
21-02-24 06:00 PM
|
(3.54 / 7.98) x | 19.42 x | 12.43 x |
|
Day 4
22-02-24 06:00 PM
|
(106.72 / 369.94) x | 138.57 x | 179.07 x |
Zenith Drugs Limited Valuations
Earnings
- EPS Pre IPO
- ₹4.29/-
- EPS Post IPO
- ₹6.29/-
- P/E Pre IPO
- 18.4
- P/E Post IPO
- 12.56
Returns
- ROE
- 35.13%
- ROCE
- 37.29%
- RoNW
- 29.88%
Fundamentals
- Debt / Equity
- 1.51
- Price / Book
- 5.50
Zenith Drugs Limited Financials( In Lakhs)
| 30-Sep-23 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 11,249.04 | 9,793.83 | 6,858.47 |
| Revenue | 6,948.43 | 11,569.65 | 9,266.63 |
| Profit After Tax | 539.38 | 515.29 | 312.86 |
| Net Worth | 2,264.96 | 1,724.42 | 1,209.09 |
| Reserves & Surplus | 1,064.96 | 1,684.42 | 1,169.09 |
| Total Borrowing | 2,902.81 | 2,605.03 | 1,880.86 |
Zenith Drugs Limited Company & Offer Insights
About Zenith Drugs Limited
Zenith Drugs Limited is a pharma company which was incorporated in the year 2000. Its products include medicines that are highly quality and are sold at relatively low prices in the market as well as generics.
The organization complies with WHO-GMP and has got ISO 9001:2015 certification issued by EuroUK recognized certification body.
Product portfolio comprises of:
ORS Powder
Liquid Orals
Ointments;
Liquid Externals; and
Capsules
The Food & Drugs Administration has certified more than 600 products from the company that are being put into production 325 in stock.The establishment of a manufacturing facility in an area known as Village Muradpura at Depalpur, Indore, Madhya Pradesh is under operation.
The company sells its products to countries in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.Zenith Drugs Limited is into third-party manufacturing, or white label manufacturing, for respected pharmaceutical companies like Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.
As of 31 March, 2023, there were 89 staff; 61 of them were payroll employees while the rest are 28 are contractual.
Zenith Drugs Limited Promoter(s)
Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni, Mr. Ajay Singh Dassundi are the company's promoters of Zenith Drugs Limited.
Zenith Drugs Limited IPO Issue Objectives
- •
- Purchase of Machinery & Equipments for Setting up New Unit
- •
- Existing Manufacturing Block Upgradation
- •
- Working Capital Requirements
- •
- General Corporate Purposes.
Contact Information
Contact Details
Zenith Drugs Limited
+91 8435501867
K. No. 72 / 5, Village Muradpura, NA Depalpur, Indore-453001
Frequently Asked Questions
Click any question to reveal the answer
Zenith Drugs Limited IPO is a book-built IPO worth ₹40.68 crore. The price band is ₹75–₹79 per share. The IPO opens on Feb 19, 2024 and closes on Feb 22, 2024. It will be listed on NSE SME Platform. Bigshare Services Pvt Ltd is the registrar.
The price band of Zenith Drugs Limited IPO is ₹75 to ₹79 per share.
The lot size of Zenith Drugs Limited IPO is 1600 shares.
The minimum investment for Zenith Drugs Limited IPO is approximately ₹1,26,400 based on the upper price band .
Zenith Drugs Limited IPO opens on Feb 19, 2024 and closes on Feb 22, 2024.
The allotment date of Zenith Drugs Limited IPO is Feb 23, 2024.
Zenith Drugs Limited IPO is expected to be listed on Feb 27, 2024, on NSE SME Platform.
Zenith Drugs Limited IPO valuation snapshot: P/E 12.56, EPS ₹6.29/-, P/B 5.50, RoNW 29.88%, and market cap N/A.
To apply for Zenith Drugs Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Zenith Drugs Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Zenith Drugs Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Zenith Drugs Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Zenith Drugs Limited IPO allotment status on IPO Ji for quick and easy access.